Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Spyre Therapeutics (SYRE) EPS (Weighted Average and Diluted): 2020-2024

Historic EPS (Weighted Average and Diluted) for Spyre Therapeutics (SYRE) over the last 5 years, with Dec 2024 value amounting to -$127.21.

  • Spyre Therapeutics' EPS (Weighted Average and Diluted) rose 99.64% to -$0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was -$32.77, marking a year-over-year increase of 95.03%. This contributed to the annual value of -$127.21 for FY2024, which is 76.88% up from last year.
  • According to the latest figures from FY2024, Spyre Therapeutics' EPS (Weighted Average and Diluted) is -$127.21, which was up 76.88% from -$550.29 recorded in FY2023.
  • In the past 5 years, Spyre Therapeutics' EPS (Weighted Average and Diluted) registered a high of -$1.52 during FY2020, and its lowest value of -$550.29 during FY2023.
  • Over the past 3 years, Spyre Therapeutics' median EPS (Weighted Average and Diluted) value was -$127.21 (recorded in 2024), while the average stood at -$234.12.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first crashed by 2,113.56% in 2023, then soared by 76.88% in 2024.
  • Over the past 5 years, Spyre Therapeutics' EPS (Weighted Average and Diluted) (Yearly) stood at -$1.52 in 2020, then plummeted by 1,546.05% to -$25.02 in 2021, then climbed by 0.64% to -$24.86 in 2022, then crashed by 2,113.56% to -$550.29 in 2023, then soared by 76.88% to -$127.21 in 2024.